참고문헌
- Thomson, A. W. In Therapeutic Immunosuppression; Kluwer Academic Publishers: 2001; p 130
- Bohlin, L. Phytochem. Rev. 1995, 37, 137
- Pawson, T.; Scott, J. D. Science 1997, 278, 2075 https://doi.org/10.1126/science.278.5346.2075
- Shaw, K. T.; Ho, A. M.; Raghavan, A.; Kim, J.; Jain, J.; Park, J.; Sharma, S.; Rao, A.; Hogan, P. G. Proc. Natl. Acad. Sci., USA 1995, 92, 11205 https://doi.org/10.1073/pnas.92.24.11205
- Beals, C. R.; Clipstone, N. A.; Ho, S. N.; Crabtree, G. R. Genes. Dev. 1997, 11, 824 https://doi.org/10.1101/gad.11.7.824
- Aramburu, J.; Garcia-Cozar, F.; Raghavan, A.; Okamura, H.; Rao, A.; Hogan, P. G. Mol. Cell. 1998, 1, 627 https://doi.org/10.1016/S1097-2765(00)80063-5
- Aramburu, J.; Yaffe, M. B.; Lopez-Rodríguez, C.; Cantley, L. C.; Hogan, P. G.; Rao, A. Science 1999, 285, 2129 https://doi.org/10.1126/science.285.5436.2129
- Roehrl, M. H.; Kang, S.; Aramburu, J.; Wagner, G.; Rao, A.; Hogan, P. G. Proc. Natl. Acad. Sci. USA 2004, 101, 7544
- Kubinyi, H., In 3D-QSAR in Drug Design; Theory, Methods and Applications; Escom: Leiden, 1993
- Cramer, R. D.; Patterson, D. E.; Bunce, J. D. J. Am. Chem. Soc. 1988, 110, 5959 https://doi.org/10.1021/ja00226a005
- Klebe, G. Prospect Drug Discovery Des. 1998, 12, 87 https://doi.org/10.1023/A:1017025803403
- Klebe, G.; Abraham, U. J. Comput. Aid. Mol. Des. 1999, 13, 1
- Bohm, M.; Sturzebecher, J.; Klebe, G. J. Med. Chem. 1999, 42, 458 https://doi.org/10.1021/jm981062r
- Tripos Associates, Inc., 1699 S. Hanley Road, Suite 303, St. Louis, MO., 63144-2913 U.S.A., http://www.tripos.com/Bookshelf/qsar/
- Kerr, R. Biophys. J. 1964, 67, 1501 https://doi.org/10.1016/S0006-3495(94)80624-1
- Purcell, W. P.; Singer, J. A. J. Chem. Eng. Data. 1967, 12, 235 https://doi.org/10.1021/je60033a020
- Klebe, G. In 3D QSAR Drug Design, Theory, Methods and Applications: Structural Alignment of Molecules; Kubinyi, H., Ed.; ESCOM: Leiden, 1993; pp 173-199
- Marshall, G. R.; Barry, C. D.; Bosshard, H. E.; Dammkoehler, R. A.; Dunn, D. A. In Computer-Assisted Drug Design: The Conformational Parameter in Drug Design; Active Analog Approach; Olsen, E. C.; Christoffersen, R. E., Eds.; American Chemical Society: Washington, D. C. 1979; pp 205-226
- Raichurkar, A. V.; Kulkarni, V. M. J. Med. Chem. 2003, 46, 4419 https://doi.org/10.1021/jm030016a
- Stahle, L.; Wold, S. Prog. Med. Chem. 1988, 25, 291 https://doi.org/10.1016/S0079-6468(08)70281-9
- Geladi, P. J. Chemon. 1998, 2, 231
- Cramer, R. D., III.; Bunce, J. D.; Patterson, D. E. Quant. Struct. Act. Relat. 1988, 7, 18 https://doi.org/10.1002/qsar.19880070105
- Hansch, C.; Steward, A. R. J. Med. Chem. 1964, 7, 691 https://doi.org/10.1021/jm00336a001
- Fujita, T. In Progress in Physical Organic Chemistry; Taft, R., Ed.; Wiely & Sons: 1983; Vol. 14, pp 75-113
피인용 문헌
- 2D-QSAR and HQSAR of the inhibition of calcineurin-NFAT signaling by blocking protein-protein interaction with N-(4-oxo-1 (4H)-naphthalenylidene)benzenesulfonamide analogues vol.30, pp.8, 2007, https://doi.org/10.1007/BF02993966
- Prediction of the Antagonistic Activity of Aryl Benzyl Ethers against LTD4 by Using 3D-CoMFA Model Developed with Pranlukast Analogues vol.27, pp.7, 2006, https://doi.org/10.5012/bkcs.2006.27.7.1025
- Attractive Sulfur...π Interaction between Fluorinated Dimethyl Sulfur (FDMS) and Benzene vol.28, pp.6, 2005, https://doi.org/10.5012/bkcs.2007.28.6.959
- QM and Pharmacophore based 3D-QSAR of MK886 Analogues against mPGES-1 vol.29, pp.3, 2008, https://doi.org/10.5012/bkcs.2008.29.3.647